A detailed history of General American Investors CO Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, General American Investors CO Inc holds 119,900 shares of GILD stock, worth $10.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
119,900
Previous 119,900 -0.0%
Holding current value
$10.6 Million
Previous $8.78 Million 6.33%
% of portfolio
0.58%
Previous 0.63%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $1.32 Million - $1.9 Million
-21,200 Reduced 15.02%
119,900 $10.3 Million
Q1 2022

May 02, 2022

BUY
$57.92 - $72.58 $2.32 Million - $2.9 Million
40,000 Added 39.56%
141,100 $8.39 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $12,976 - $14,728
200 Added 0.2%
101,100 $7.34 Million
Q1 2021

May 03, 2021

BUY
$60.0 - $68.46 $1.56 Million - $1.78 Million
26,000 Added 34.71%
100,900 $6.52 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $2.83 Million - $3.23 Million
50,000 Added 200.8%
74,900 $4.36 Million
Q2 2020

Aug 03, 2020

SELL
$72.34 - $84.0 $4.39 Million - $5.1 Million
-60,700 Reduced 70.91%
24,900 $1.92 Million
Q1 2020

May 01, 2020

SELL
$62.63 - $80.22 $15.5 Million - $19.9 Million
-248,000 Reduced 74.34%
85,600 $6.4 Million
Q4 2018

Feb 15, 2019

SELL
$60.54 - $79.0 $2.42 Million - $3.16 Million
-40,000 Reduced 10.71%
333,600 $20.9 Million
Q3 2018

Oct 26, 2018

SELL
$71.28 - $78.92 $4.99 Million - $5.52 Million
-70,000 Reduced 15.78%
373,600 $28.8 Million
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $1.42 Million - $1.67 Million
-20,000 Reduced 4.31%
443,600 $31.8 Million
Q3 2017

Oct 27, 2017

BUY
$72.11 - $85.47 $33.4 Million - $39.6 Million
463,600
463,600 $37.6 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track General American Investors CO Inc Portfolio

Follow General American Investors CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.